Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
Main Authors: | Timothy J Kopper, John C Gensel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=3;spage=508;epage=509;aulast=Kopper |
Similar Items
-
Delayed Azithromycin Treatment Improves Recovery After Mouse Spinal Cord Injury
by: Timothy J. Kopper, et al.
Published: (2019-11-01) -
Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury.
by: John C Gensel, et al.
Published: (2012-01-01) -
Therapeutic implications of advanced age at time of spinal cord injury
by: Andrew N Stewart, et al.
Published: (2019-01-01) -
Neurological conditions associated with spinal cord injury
by: Man Amanat, et al.
Published: (2019-01-01) -
Pharmacological neuroprotection for spinal cord injury
by: Mann, Cody Mandeep
Published: (2008)